Thurston Springer Miller Herd & Titak Inc. boosted its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 18.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 36,081 shares of the company's stock after acquiring an additional 5,566 shares during the quarter. Procter & Gamble accounts for approximately 0.7% of Thurston Springer Miller Herd & Titak Inc.'s investment portfolio, making the stock its 19th biggest holding. Thurston Springer Miller Herd & Titak Inc.'s holdings in Procter & Gamble were worth $5,748,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in PG. Nova Wealth Management Inc. bought a new stake in Procter & Gamble during the first quarter worth $26,000. Capital A Wealth Management LLC acquired a new stake in shares of Procter & Gamble during the 4th quarter worth about $31,000. Quarry LP acquired a new stake in shares of Procter & Gamble during the 1st quarter worth about $33,000. 10Elms LLP acquired a new stake in shares of Procter & Gamble during the 4th quarter worth about $34,000. Finally, Sunbeam Capital Management LLC acquired a new stake in shares of Procter & Gamble during the 4th quarter worth about $34,000. 65.77% of the stock is owned by institutional investors.
Procter & Gamble Trading Down 0.4%
PG opened at $158.02 on Friday. The company's 50 day moving average is $156.21 and its 200-day moving average is $161.84. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The company has a market cap of $369.85 billion, a P/E ratio of 24.27, a PEG ratio of 4.19 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same period last year, the company posted $1.40 EPS. The firm's quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a dividend of $1.0568 per share. The ex-dividend date was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble's dividend payout ratio (DPR) is currently 64.98%.
Insider Buying and Selling at Procter & Gamble
In related news, CEO Gary A. Coombe sold 10,194 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the sale, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. This trade represents a 22.57% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Sundar G. Raman sold 9,554 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,511,060.64. Following the sale, the chief executive officer owned 41,886 shares in the company, valued at approximately $6,624,689.76. This represents a 18.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 120,181 shares of company stock worth $18,918,012 over the last quarter. Insiders own 0.20% of the company's stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on the stock. Wells Fargo & Company cut their target price on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. JPMorgan Chase & Co. restated a "neutral" rating and set a $170.00 target price (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. BNP Paribas restated an "outperform" rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. UBS Group set a $180.00 price target on shares of Procter & Gamble and gave the stock a "buy" rating in a research report on Wednesday, July 30th. Finally, Evercore ISI reaffirmed an "in-line" rating and set a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $175.12.
View Our Latest Stock Analysis on PG
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.